New Jersey Senate Bill S4323

New Jersey 2024-2025 Regular Session

• Introduced: 5/12/25
• Refer: 5/12/25

Caption

Requires health insurance coverage of screening for Alzheimer's disease and related disorders for certain covered persons.

Impact

If enacted, S4323 will require health insurance policies—including those provided by hospital service corporations, medical service corporations, health maintenance organizations, and state health benefits programs—to include coverage for Alzheimer's disease screening. These provisions mean that insurers must treat screening for Alzheimer's with the same level of importance as other health conditions, thus enhancing the healthcare safety net for the aging population in New Jersey.

Summary

Senate Bill S4323, introduced in New Jersey on May 12, 2025, mandates that health insurance carriers provide coverage for screening for Alzheimer's disease and related disorders for individuals aged 65 and older. The bill intends to ensure that older adults have access to necessary health screenings, which can facilitate early diagnosis and management of Alzheimer’s disease, thereby potentially improving patient outcomes and quality of life.

Contention

The bill may face scrutiny regarding its implications on insurance premiums and healthcare costs. While proponents argue that the legislation will reduce long-term healthcare expenses by promoting early detection and intervention, critics may raise concerns about the financial burden on insurers and how these costs will ultimately be passed on to consumers. Thus, the dialogue surrounding S4323 involves balancing the healthcare needs of seniors with the economic realities of the health insurance market.